CVS agrees to pay $315 million to settle Justice Department case over opioid prescriptions
CVS Health and its subsidiaries have agreed to pay $315 million to resolve a Justice Department case alleging the company unlawfully dispensed medically unnecessary and highly addictive opioid prescriptions. The settlement addresses federal claims of illegal opioid prescription practices and fraud. Multiple news organizations and legal sources confirmed the financial agreement, which targets allegations that pharmacists filled unlawful prescriptions. The company agreed to the payout to close the federal scrutiny regarding its prescription dispensing procedures.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ CVS agreed to pay $315 million to settle a Justice Department case over opioid prescriptions.
- ✓ The settlement resolves claims involving unlawful and medically unnecessary opioid prescriptions.
- ✓ CVS Pharmacy Inc. and various subsidiaries are parties to the agreement.
What changed
CVS agreed to pay $315 million to resolve Justice Department allegations regarding illegal opioid prescriptions.
Live updates
-
CVS Agrees to $315 Million DOJ Opioid Settlement
CVS Health and its subsidiaries have agreed to pay $315 million to resolve a Justice Department case alleging the company unlawfully dispensed medically unnecessary and highly addictive opioid prescriptions. The settlement addresses federal claims of illegal opioid prescription practices and fraud. Multiple news organizations and legal sources confirmed the financial agreement, which targets allegations that pharmacists filled unlawful prescriptions. The company agreed to the payout to close the federal scrutiny regarding its prescription dispensing procedures.
Why it matters
The settlement targets pharmaceutical dispensing practices that fueled the national opioid crisis, bringing federal scrutiny to one of the country's largest pharmacy operators. Regulatory authorities have increasingly targeted corporate dispensing habits as part of broader efforts to hold pharmacy chains accountable for controlled substances. Most of the violations identified in the allegations took place under Foulkes, according to regional reporting.
What is confirmed
- CVS agreed to pay $315 million to settle a Justice Department case over opioid prescriptions.
- The settlement resolves claims involving unlawful and medically unnecessary opioid prescriptions.
- CVS Pharmacy Inc. and various subsidiaries are parties to the agreement.
Still unconfirmed
- Most violations took place under Foulkes.
What to watch next
- Final court approval or formal filing details of the $315 million settlement
- Official statements from CVS Health regarding operational compliance changes following the agreement
confidence 100%Sources used for this update (28)
- finance.yahoo.com — Yahoo Finance - Stock Market Live, Quotes, Business & Finance News
- www.nbcnews.com — NBC News - Breaking Headlines and Video Reports on World, U.S....
- abcnews.com — ABC News - Breaking News, Latest News and Videos
- AP News — CVS agrees to pay $315 million to settle Justice Department case over opioid prescriptions
- WSJ — CVS Health Unit to Pay $315 Million to Resolve Illegal Opioid Prescription Claims
- KOMO — CVS agrees to $315M settlement over opioid prescriptions: DOJ
- Seeking Alpha — CVS to pay $315M to feds over opioid prescription allegations (CVS:NYSE)
- Reuters — CVS to pay $315 million to settle unlawful opioid prescription claims, Justice Department says
- GuruFocus — CVS Health Settles $315M Opioid Prescription Claims, Ticker CVS Reacts
- Bloomberg Law News — CVS Agrees to $315 Million Opioid Prescription Fraud Settlement
- The Hill — CVS to pay $315M settlement over allegations of illegally filling opioid prescriptions
- Forbes — CVS Agrees To $315 Million Settlement Over Opioid Prescriptions
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community